![]() | Up a level |
Townsend, Tristan, Razanskaite, Violeta, Dodd, Susanna ORCID: 0000-0003-2851-3337, Storey, Daniel, Michail, Stephanie, Morgan, James, Davies, Michael, Penman, Douglas, Watters, Christopher, Swaminathan, Mira et al (show 7 more authors)
(2020)
Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti‐TNF‐refractory Crohn’s disease.
Alimentary Pharmacology and Therapeutics, 52 (8).
pp. 1341-1352.
Smith, Philip, Critchley, Lisa, Storey, Daniel ORCID: 0000-0001-8101-8429, Gregg, Belle, Stenson, June, Kneebone, Andrew, Rimmer, Tracy, Burke, Stevena, Hussain, Shamas, Teoh, Wan Yi et al (show 10 more authors)
(2022)
EFFICACY AND SAFETY OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS IFX (CT-P13): A MULTI-CENTRE COHORT STUDY.
In: Abstracts of the BSG Annual Meeting, 20–23 June 2022.
Smith, Philip J, Critchley, Lisa, Storey, Daniel, Gregg, Belle, Stenson, June, Kneebone, Andrew, Rimmer, Tracy, Burke, Stevena, Hussain, Shamas, Yi Teoh, Wan et al (show 10 more authors)
(2022)
Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort Study.
JOURNAL OF CROHNS & COLITIS, 16 (9).
pp. 1436-1446.